FAR1

UniProt ID: Q8WVX9
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

FAR1 (fatty acyl-CoA reductase 1) is an NADPH-dependent, peroxisomal-membrane oxidoreductase that catalyzes the two-step reduction of long-chain fatty acyl-CoA (preferring saturated and unsaturated C16 and C18 species such as palmitoyl-, stearoyl- and oleoyl-CoA) to the corresponding primary fatty alcohol, with release of CoA (EC 1.2.1.84). It is a C-terminally tail-anchored, single-pass peroxisomal membrane protein whose targeting is mediated by the PEX19 receptor, with a large cytoplasmic catalytic domain. The fatty alcohols it produces are the committed precursors for ether-lipid (plasmalogen) biosynthesis, where alkyl-dihydroxyacetone-phosphate synthase (AGPS) uses them to form the characteristic ether bond; FAR1 is the rate-limiting enzyme of this pathway and is feedback-regulated by cellular plasmalogen levels through modulation of its protein stability. Its fatty alcohol product also feeds wax monoester synthesis. Loss-of-function of FAR1 causes an autosomal-recessive peroxisomal disorder (severe intellectual disability, epilepsy, cataracts), and gain-of-function variants that escape plasmalogen feedback cause an autosomal-dominant cataract/spastic-paraparesis syndrome.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005778 peroxisomal membrane
IBA
GO_REF:0000033
ACCEPT
Summary: FAR1 is a single-pass peroxisomal membrane protein; the phylogenetic (IBA) assignment of peroxisomal membrane as its active-in location is correct and represents a core aspect of the gene. Directly supported by experimental data (tail-anchored peroxisomal membrane protein).
Supporting Evidence:
PMID:24108123
Far1 is shown to be a peroxisomal tail-anchored protein
GO:0080019 alcohol-forming very long-chain fatty acyl-CoA reductase activity
IBA
GO_REF:0000033
MARK AS OVER ANNOTATED
Summary: The alcohol-forming acyl-CoA reductase activity type is correct, but the chain-length specialization is wrong for human FAR1: this term is for VERY long-chain (>22C) substrates, whereas FAR1 preferentially reduces C16/C18 (long-chain, 13-22C) fatty acyl-CoA. The very-long-chain term is a family-level (phylogenetic) over-annotation; the correct, experimentally supported term is GO:0102965 (alcohol-forming long-chain fatty acyl-CoA reductase activity).
Propagation Review
Root cause: TERM SCOPING PROBLEM
Failure modes: GRANULARITY MISMATCH WRONG ORTHOLOG OR PARALOG
Sources checked:
PANTHER:PTN000110226 Β· fatty acyl-CoA reductase family node (includes plant/insect FARs acting on very-long-chain substrates) SUPPORTS SOURCE BUT NOT TARGET
Supporting Evidence:
file:human/FAR1/FAR1-uniprot.txt
Catalyzes the reduction of saturated and unsaturated C16 or
GO:0035336 long-chain fatty-acyl-CoA metabolic process
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: FAR1 consumes long-chain (C16/C18) fatty acyl-CoA as its substrate, so participation in long-chain fatty-acyl-CoA metabolic process is correct. This is a somewhat generic process descriptor; the core biological role is better captured by ether lipid biosynthesis, but the annotation is valid.
Supporting Evidence:
PMID:15220348
FAR1 preferred saturated
GO:0005777 peroxisome
IEA
GO_REF:0000117
ACCEPT
Summary: Peroxisome localization is the correct, experimentally established location of FAR1. This electronic annotation is redundant with, and supported by, the IDA/HPA peroxisome annotations; accept as a core cellular component.
Supporting Evidence:
PMID:15220348
were localized in the peroxisome
GO:0005778 peroxisomal membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Peroxisomal membrane is the correct location of this single-pass tail-anchored membrane protein. This Subcellular-Location-mapping IEA is redundant with the IDA/HDA evidence; accept as a core cellular component.
Supporting Evidence:
file:human/FAR1/FAR1-uniprot.txt
Single-pass membrane protein
GO:0008610 lipid biosynthetic process
IEA
GO_REF:0000117
MARK AS OVER ANNOTATED
Summary: A very high-level parent term. FAR1 does participate in lipid biosynthesis, but this generic ARBA-derived annotation is uninformative and redundant with the specific ether-lipid / wax / glycerophospholipid biosynthetic process annotations.
GO:0016620 oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor
IEA
GO_REF:0000117
MARK AS OVER ANNOTATED
Summary: This term describes oxidation of an aldehyde/oxo donor with NAD(P) as acceptor. The physiological FAR1 reaction reduces fatty acyl-CoA (with NADPH as donor) to a fatty alcohol; the aldehyde is a transient intermediate and the acceptor/donor direction of this generic term does not accurately capture the enzyme's function. Better captured by the specific alcohol-forming acyl-CoA reductase term (GO:0102965). Generic ARBA over-annotation.
GO:0080019 alcohol-forming very long-chain fatty acyl-CoA reductase activity
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: Same issue as the IBA assignment of this term: the InterPro family maps to alcohol-forming acyl-CoA reductase activity, but human FAR1 prefers C16/C18 (long-chain) rather than very-long-chain (>22C) substrates. The correct term is GO:0102965.
Supporting Evidence:
file:human/FAR1/FAR1-uniprot.txt
Catalyzes the reduction of saturated and unsaturated C16 or
GO:0102965 alcohol-forming long-chain fatty acyl-CoA reductase activity
IEA
GO_REF:0000120
ACCEPT
Summary: This is the correct core molecular function of FAR1: alcohol-forming long-chain (C16/C18) fatty acyl-CoA reductase activity (EC 1.2.1.84). This electronic (RHEA/EC-based) annotation agrees with the experimental IDA annotations; accept as the core function.
Supporting Evidence:
file:human/FAR1/FAR1-uniprot.txt
Reaction=a long-chain fatty acyl-CoA + 2 NADPH + 2 H(+) = a long-chain
GO:1901568 fatty acid derivative metabolic process
IEA
GO_REF:0000117
MARK AS OVER ANNOTATED
Summary: Generic high-level process term. FAR1's product (fatty alcohol) is a fatty acid derivative, so the annotation is not wrong, but it is uninformative and redundant with the specific biosynthetic-process annotations. Generic ARBA over-annotation.
GO:0005515 protein binding
IPI
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative ...
MARK AS OVER ANNOTATED
Summary: Bare 'protein binding' from a large-scale yeast two-hybrid interactome (IntAct records with KLF11, a BAG6 isoform, and a COL26A1 isoform). These high-throughput interactions have no established biological role for FAR1 and the term is uninformative. Retained per policy (IPI protein binding), but marked as over-annotated. The functionally meaningful interaction (PEX19, for peroxisomal targeting) is a distinct, literature-curated interaction (PMID:24108123).
GO:0010025 wax biosynthetic process
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: FAR1's fatty-alcohol product is a precursor for wax monoester synthesis; wax biosynthetic process is a valid downstream role, largely inferred from the mouse ortholog and Reactome. It is not the primary (ether-lipid) role in human, so keep as non-core.
Supporting Evidence:
file:human/FAR1/FAR1-uniprot.txt
also required for wax monoesters
GO:0010025 wax biosynthetic process
TAS
Reactome:R-HSA-9640463
KEEP AS NON CORE
Summary: Same wax biosynthetic role, asserted by Reactome. Valid downstream use of the fatty-alcohol product; keep as non-core (the principal human role is ether-lipid/plasmalogen biosynthesis).
Supporting Evidence:
Reactome:R-HSA-9640463
FAR1 and FAR2 catalyze the reduction of fatty acids to fatty alcohols
GO:0005777 peroxisome
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence (HPA) localization to the peroxisome; consistent with confocal microscopy in the original characterization and with the membrane-topology study. Core cellular component.
Supporting Evidence:
PMID:15220348
were localized in the peroxisome
GO:0102965 alcohol-forming long-chain fatty acyl-CoA reductase activity
IDA
PMID:15220348
Mammalian wax biosynthesis. I. Identification of two fatty a...
ACCEPT
Summary: Direct experimental demonstration that FAR1 reduces C16/C18 fatty acyl-CoA to fatty alcohols in an NADPH-dependent manner. This is the core molecular function of the gene.
Supporting Evidence:
PMID:15220348
FAR1 preferred saturated
GO:0102965 alcohol-forming long-chain fatty acyl-CoA reductase activity
IDA
PMID:20071337
Posttranslational regulation of fatty acyl-CoA reductase 1, ...
ACCEPT
Summary: Direct evidence supporting the alcohol-forming long-chain fatty acyl-CoA reductase activity of FAR1 (fatty-alcohol supply for ether-bond formation). Core molecular function.
Supporting Evidence:
PMID:20071337
supplies the fatty alcohols used in the
GO:0102965 alcohol-forming long-chain fatty acyl-CoA reductase activity
IDA
PMID:24108123
Topogenesis and homeostasis of fatty acyl-CoA reductase 1.
ACCEPT
Summary: Direct evidence for FAR1's alcohol-forming fatty acyl-CoA reductase activity (Far1 expression increases plasmalogen synthesis; rate-limiting enzyme). Core molecular function.
Supporting Evidence:
PMID:24108123
Far1 is a rate-limiting enzyme for plasmalogen synthesis
GO:0016491 oxidoreductase activity
TAS
Reactome:R-HSA-390425
KEEP AS NON CORE
Summary: FAR1 is an oxidoreductase; this Reactome-asserted parent term is correct but very generic. The specific molecular function (GO:0102965) is preferred; keep this general term as non-core.
Supporting Evidence:
Reactome:R-HSA-390425
FAR1 catalyzes the reaction of palmitoyl-CoA (PalmCoA) and 2 NADPH
GO:0005778 peroxisomal membrane
TAS
Reactome:R-HSA-390425
ACCEPT
Summary: Peroxisomal membrane localization asserted by Reactome; correct and consistent with the experimental topology data. Core cellular component.
Supporting Evidence:
PMID:24108123
Far1 is shown to be a peroxisomal tail-anchored protein
GO:0010025 wax biosynthetic process
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: Wax biosynthetic role inferred by sequence similarity from the mouse ortholog (Q922J9). Valid downstream use of the fatty-alcohol product; keep as non-core (ether-lipid biosynthesis is the primary human role).
Supporting Evidence:
file:human/FAR1/FAR1-uniprot.txt
also required for wax monoesters
GO:0005778 peroxisomal membrane
IDA
PMID:24108123
Topogenesis and homeostasis of fatty acyl-CoA reductase 1.
ACCEPT
Summary: Direct experimental evidence that FAR1 is a peroxisomal tail-anchored, single-pass membrane protein targeted via PEX19. Core cellular component.
Supporting Evidence:
PMID:24108123
Far1 is shown to be a peroxisomal tail-anchored protein
GO:0008611 ether lipid biosynthetic process
IDA
PMID:24108123
Topogenesis and homeostasis of fatty acyl-CoA reductase 1.
ACCEPT
Summary: Direct evidence that FAR1 is required for and rate-limiting in ether lipid/plasmalogen biosynthesis (Far1 supplies the fatty alcohols for ether-bond formation; its expression increases plasmalogen synthesis). This is the core biological process of the gene.
Supporting Evidence:
PMID:24108123
Peroxisomal fatty acyl-CoA reductase 1 (Far1) is essential for supplying fatty alcohols required for ether bond formation in ether glycerophospholipid synthesis
GO:0008611 ether lipid biosynthetic process
IMP
PMID:20071337
Posttranslational regulation of fatty acyl-CoA reductase 1, ...
ACCEPT
Summary: Manipulation of Far1 (levels/activity modulated by plasmalogen feedback) controls ether glycerophospholipid synthesis, supporting involvement in ether lipid biosynthesis. Core biological process.
Supporting Evidence:
PMID:20071337
supplies the fatty alcohols used in the
GO:0035336 long-chain fatty-acyl-CoA metabolic process
IDA
PMID:15220348
Mammalian wax biosynthesis. I. Identification of two fatty a...
KEEP AS NON CORE
Summary: FAR1 acts on long-chain (C16/C18) fatty acyl-CoA substrates, consistent with participation in long-chain fatty-acyl-CoA metabolic process. Correct but generic process descriptor; keep as non-core relative to ether-lipid biosynthesis.
Supporting Evidence:
PMID:15220348
FAR1 preferred saturated
GO:0046474 glycerophospholipid biosynthetic process
IDA
PMID:20071337
Posttranslational regulation of fatty acyl-CoA reductase 1, ...
KEEP AS NON CORE
Summary: Ether glycerophospholipids (plasmalogens) are glycerophospholipids, so this annotation is correct; it is a more general parent of the ether-lipid-specific process. Keep as non-core; the specific term GO:0008611 better captures the role.
Supporting Evidence:
PMID:20071337
supplies the fatty alcohols used in the
GO:0005777 peroxisome
IDA
PMID:20071337
Posttranslational regulation of fatty acyl-CoA reductase 1, ...
ACCEPT
Summary: Direct experimental localization of Far1 to the peroxisome. Core cellular component.
Supporting Evidence:
PMID:15220348
were localized in the peroxisome
GO:0005778 peroxisomal membrane
HDA
PMID:21525035
PEX14 is required for microtubule-based peroxisome motility ...
ACCEPT
Summary: FAR1 was identified in native peroxisomal membrane protein complexes isolated from human cells by proteomics, corroborating its peroxisomal membrane localization. Core cellular component.
Supporting Evidence:
PMID:21525035
isolating native peroxisomal membrane

Core Functions

NADPH-dependent reduction of long-chain (C16/C18) fatty acyl-CoA to the corresponding primary fatty alcohol (EC 1.2.1.84), the committed step that supplies fatty alcohols for ether-lipid biosynthesis.

Supporting Evidence:
  • PMID:15220348
    FAR1 preferred saturated
  • file:human/FAR1/FAR1-uniprot.txt
    Reaction=a long-chain fatty acyl-CoA + 2 NADPH + 2 H(+) = a long-chain

As the rate-limiting enzyme supplying fatty alcohols, FAR1 drives ether-lipid (plasmalogen) biosynthesis, acting at the peroxisomal membrane; its product is used by AGPS to form the ether bond.

Supporting Evidence:

References

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(FAR1-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)